|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 261.07 USD | +3.99% |
|
+7.37% | +14.26% |
| 07-02 | AbbVie, Other Healthcare Stocks Rise as Trump Administration Reportedly Targets Hospital Drug Markups | MT |
| 07-01 | US Committee Launches Probe Against Five Drugmakers Over China Clinical Trials | MT |
| Market Cap | 461B 403B 370B 346B 655B 43,912B 665B 4,448B 1,729B 21,564B 1,732B 1,694B 74,418B | P/E 2026 * |
32.2x | P/E 2027 * | 24.5x |
|---|---|---|---|---|---|
| Enterprise Value | 517B 452B 415B 387B 734B 49,225B 745B 4,987B 1,938B 24,173B 1,941B 1,899B 83,422B | EV / Sales 2026 * |
7.69x | EV / Sales 2027 * | 6.98x |
| Free-Float |
95.71% | Yield 2026 * |
2.65% | Yield 2027 * | 2.77% |
Last Transcript: AbbVie Inc.
| 1 day | +3.99% | ||
| 1 week | +7.37% | ||
| Current month | +3.75% | ||
| 1 month | +21.20% | ||
| 3 months | +25.01% | ||
| 6 months | +13.85% | ||
| Current year | +14.26% |
| 1 week | 247.56 |  | 261.64 |
| 1 month | 215.37 | | 261.64 |
| Current year | 190.75 | | 261.64 |
| 1 year | 184.63 | | 261.64 |
| 3 years | 132.7 | | 261.64 |
| 5 years | 105.56 | | 261.64 |
| 10 years | 55.06 | | 261.64 |
| Manager | Title | Age | Since |
|---|---|---|---|
Robert Michael
CEO | Chief Executive Officer | 55 | 2024-06-30 |
Scott Reents
DFI | Director of Finance/CFO | 59 | 2022-06-22 |
Linda Ray
CTO | Chief Tech/Sci/R&D Officer | - | 2024-02-29 |
| Director | Title | Age | Since |
|---|---|---|---|
Roxanne Austin
BRD | Director/Board Member | 65 | 2012-12-31 |
William Burnside
BRD | Director/Board Member | 74 | 2012-12-31 |
Edward Rapp
BRD | Director/Board Member | 68 | 2012-12-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 05-07 | Free | Director | 1,118 | 0.0001% | ||
| 05-07 | Free | Director | 1,118 | 0.0001% | ||
| 05-07 | Free | Director | 1,118 | 0.0001% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +3.99% | +7.37% | +36.87% | +93.77% | 461B | |
| +1.86% | +7.65% | +55.77% | +158.84% | 1,082B | |
| +3.57% | +7.42% | +69.09% | +58.92% | 633B | |
| +3.86% | +1.85% | +31.30% | +24.86% | 339B | |
| -0.56% | +2.80% | +39.13% | +28.20% | 301B | |
| -0.08% | +1.52% | +29.96% | +42.13% | 292B | |
| -1.54% | +3.56% | -25.96% | -40.53% | 225B | |
| +3.55% | +6.05% | +26.04% | +68.52% | 202B | |
| +4.21% | +6.00% | +17.72% | +70.33% | 163B | |
| +1.84% | +2.75% | -3.95% | -33.70% | 139B | |
| Average | +2.07% | +4.36% | +27.60% | +47.13% | 383.83B | |
| Weighted average by Cap. | +2.23% | +5.32% | +40.13% | +76.40% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 67.24B 58.81B 53.97B 50.38B 95.46B 6,401B 96.88B 648B 252B 3,143B 252B 247B 10,848B | 72.73B 63.61B 58.38B 54.5B 103B 6,924B 105B 701B 273B 3,400B 273B 267B 11,734B |
| Net income | 14.56B 12.73B 11.69B 10.91B 20.67B 1,386B 20.98B 140B 54.58B 681B 54.67B 53.48B 2,349B | 19.02B 16.64B 15.27B 14.25B 27.01B 1,811B 27.41B 183B 71.31B 889B 71.42B 69.87B 3,069B |
| Net Debt | 55.81B 48.81B 44.8B 41.82B 79.24B 5,313B 80.42B 538B 209B 2,609B 210B 205B 9,004B | 46.34B 40.52B 37.19B 34.72B 65.79B 4,411B 66.77B 447B 174B 2,166B 174B 170B 7,476B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-02 | US$261.07 | +3.99% | 7,114,422 |
| 26-07-01 | US$251.06 | -0.23% | 6,987,982 |
| 26-06-30 | US$251.64 | -1.05% | 6,999,707 |
| 26-06-29 | US$254.31 | +0.38% | 9,760,531 |
| 26-06-26 | US$253.35 | +4.20% | 52,635,078 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ABBV Stock
Select your edition
All financial news and data tailored to specific country editions
